Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alnylam Pharmaceuticals Inc (ALNY)  
$151.22 3.82 (2.59%) as of 4:30 Thu 5/16


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,030,000
Market Cap: 18.60(B)
Last Volume: 934,860 Avg Vol: 724,527
52 Week Range: $143.31 - $211.65
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  824
Guru Rank Value     : 0.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 45,264 76,855 102,504 247,093
Total Sell Value $6,835,665 $12,957,715 $17,713,340 $48,829,179
Total People Sold 6 7 8 9
Total Sell Transactions 10 12 18 35
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 746
  Page 16 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Maraganore John Chief Executive Officer   •       •      –    2016-01-20 4 OE $22.75 $342,979 D/D 15,076 148,465     -
   Maraganore John Chief Executive Officer   •       •      –    2016-01-19 4 AS $70.95 $1,116,985 D/D (15,076) 133,389     -
   Maraganore John Chief Executive Officer   •       •      –    2016-01-19 4 OE $22.75 $342,979 D/D 15,076 148,465     -
   Sharp Philip A Director   –       •      –    2015-12-04 4 AS $109.00 $3,270,000 D/D (30,000) 140,795     -
   Sharp Philip A Director   –       •      –    2015-12-04 4 OE $14.05 $428,400 D/D 30,000 170,795     -
   Maraganore John Chief Executive Officer   •       •      –    2015-12-02 4 AS $103.15 $6,154,715 D/D (58,689) 133,389     -
   Maraganore John Chief Executive Officer   •       •      –    2015-12-02 4 OE $13.12 $770,000 D/D 58,689 192,078     -
   Vaishnaw Akshay EVP, R&D, CMO   •       –      –    2015-11-25 4 OE $16.43 $99,750 D/D 5,750 5,750     -
   Maraganore John Chief Executive Officer   •       •      –    2015-11-20 4 AS $102.34 $6,037,933 D/D (58,690) 133,389     -
   Maraganore John Chief Executive Officer   •       •      –    2015-11-20 4 OE $7.10 $845,017 D/D 69,254 192,079     -
   Schimmel Paul Director   –       •      –    2015-11-19 4 GD $0.00 $0 I/I 4,000 306,996     -
   Greene Barry E President and COO   •       –      –    2015-11-18 4 GD $0.00 $0 D/D 2,100 48,264     -
   Starr Kevin P Director   –       •      –    2015-11-12 4 AS $100.01 $3,755,085 D/D (37,500) 0     -
   Starr Kevin P Director   –       •      –    2015-11-12 4 OE $11.33 $537,125 D/D 37,500 37,500     -
   Starr Kevin P Director   –       •      –    2015-11-11 4 AS $105.31 $4,037,033 D/D (37,500) 0     -
   Starr Kevin P Director   –       •      –    2015-11-11 4 OE $9.30 $374,125 D/D 37,500 37,500     -
   Greene Barry E President and COO   •       –      –    2015-08-04 4 OE $9.14 $505,124 D/D 26,972 50,364     -
   Vaishnaw Akshay EVP, R&D, CMO   •       –      –    2015-06-16 4 AS $128.10 $1,127,239 D/D (8,750) 0     -
   Vaishnaw Akshay EVP, R&D, CMO   •       –      –    2015-06-16 4 OE $7.10 $75,875 D/D 8,750 8,750     -
   Sharp Philip A Director   –       •      –    2015-06-01 4 D $0.00 $0 I/I (25,844) 126,104     -
   Sharp Philip A Director   –       •      –    2015-06-01 4 A $0.00 $0 D/D 25,844 140,795     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2015-06-01 4 AS $130.39 $631,646 D/D (4,791) 0     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2015-06-01 4 OE $10.98 $220,526 D/D 4,791 4,791     -
   Greene Barry E President and COO   •       –      –    2015-05-26 4 AS $125.00 $8,422,375 D/D (67,379) 23,392     -
   Greene Barry E President and COO   •       –      –    2015-05-26 4 OE $13.12 $884,012 D/D 67,379 90,771     -
  746 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 16 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us